DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells

por Trapani, V, Patel, V, Leong, C-O, Ciolino, H P, Yeh, G C, Hose, C, Trepel, J B, Stevens, M F G, Sausville, E A, Loaiza-Pérez, A I
Publicado 2003

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts

por Purohit, A, Singh, A, Ghilchik, M W, Serlupi-Crescenzi, O, Reed, M J
Publicado 2003

Rapid deterioration in quality of life during interleukin-2- and α-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

por Atzpodien, J, Küchler, Th, Wandert, T, Reitz, M
Publicado 2003

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma

por Miyazaki, T, Kato, H, Nakajima, M, Sohda, M, Fukai, Y, Masuda, N, Manda, R, Fukuchi, M, Tsukada, K, Kuwano, H
Publicado 2003

Temporal heterogeneity in oxygen tension in human melanoma xenografts

por Brurberg, K G, Graff, B A, Rofstad, E K
Publicado 2003

Brostallicin (PNU-166196) – a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells

por Fedier, A, Fowst, C, Tursi, J, Geroni, C, Haller, U, Marchini, S, Fink, D
Publicado 2003

Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study

por Gago-Dominguez, M, Yuan, J-M, Sun, C-L, Lee, H-P, Yu, M C
Publicado 2003

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

por Höpfner, M, Sutter, A P, Gerst, B, Zeitz, M, Scherübl, H
Publicado 2003

Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells

por Eves, P, Haycock, J, Layton, C, Wagner, M, Kemp, H, Szabo, M, Morandini, R, Ghanem, G, García-Borrón, J C, Jiménez-Cervantes, C, Mac Neil, S
Publicado 2003

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

por O'Brien, S G, Meinhardt, P, Bond, E, Beck, J, Peng, B, Dutreix, C, Mehring, G, Milosavljev, S, Huber, C, Capdeville, R, Fischer, T
Publicado 2003

Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protra...

por Yamada, Y, Hamaguchi, T, Goto, M, Muro, K, Matsumura, Y, Shimada, Y, Shirao, K, Nagayama, S
Publicado 2003

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma

por Mabed, M, El-Helw, L, Shamaa, S
Publicado 2004

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

por Gori, S, Colozza, M, Mosconi, A M, Franceschi, E, Basurto, C, Cherubini, R, Sidoni, A, Rulli, A, Bisacci, C, Angelis, V De, Crinò, L, Tonato, M
Publicado 2004

Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis

por Strojan, P, Oblak, I, Svetic, B, Šmid, L, Kos, J
Publicado 2004

Why does specialist treatment of breast cancer improve survival? The role of surgical management

por Kingsmore, D, Hole, D, Gillis, C
Publicado 2004

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado 2004

In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

por Barthel, H, Wilson, H, Collingridge, D R, Brown, G, Osman, S, Luthra, S K, Brady, F, Workman, P, Price, P M, Aboagye, E O
Publicado 2004

Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-tim...

por Sakakura, C, Takemura, M, Hagiwara, A, Shimomura, K, Miyagawa, K, Nakashima, S, Yoshikawa, T, Takagi, T, Kin, S, Nakase, Y, Fujiyama, J, Hayasizaki, Y, Okazaki, Y, Yamagishi, H
Publicado 2004

Declining mortality from breast cancer in Yorkshire, 1983–1998: extent and causes

por Pisani, P, Forman, D
Publicado 2004

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie...

por Body, J J, Diel, I J, Lichinitzer, M, Lazarev, A, Pecherstorfer, M, Bell, R, Tripathy, D, Bergstrom, B
Publicado 2004